In 2023, Qingdao LuJian established a new R&D and incubation platform in the Economic Development Zone of Chengdu, Sichuan Province—the Sichuan Innovation Technology Co., Ltd. As an independent third-party R&D - oriented incubation platform, it concentrates on the research, production, and service of medical device materials and products. Based on the medical device registrant system, it has built the first CDMO platform in China's western region that meets the US FDA and Chinese Medical Device GMP regulations for R&D transformation, production, and service of Class III medical devices. The platform offers full - cycle solutions for "compliance of product industrialization from concept to market entry", truly enabling breakthroughs in medical devices from 0 to N.
The platform provides full - industry - chain consultation and technical services, including regulatory consulting, process design, validation and confirmation, R&D transformation, registration application, scale - up production, and product iteration. It helps research institutes, clinical institutions, and domestic and international medical enterprises reduce R&D and production costs, plan product registration paths, shorten time - to - market, lower regulatory risks, and enhance project transformation success rates. So far, it has undertaken R&D transformation of several domestic and international high - value surgical consumables. CDMO Philosophy: Innovation Beyond Rivals!
.jpg)
Mobile phone |
